TAP vs VKTX · rev $13.04B vs $3.97B cap
TAP (TAP) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
TAP (TAP) common stock.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
TAP currently screens at market cap $0. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the TAP and VKTX stock pages for the full models.
Not investment advice.